Sex and gender matter to health equity, especially in a pandemic. Sex (a biological attribute) and gender (a social construct) may influence an individual's susceptibility, vulnerability and exposure to infectious disease. In previous coronavirus epidemics (SARS and MERS), male sex was associated with worse outcomes. Both immune and the hemostatic response display ample sexual dimorphism. The primary aim of the study is to determine whether sex differences in biomarkers of platelet and immune function, gut microbiome, clinical characteristics, therapy, clinical cost sensitive outcomes (i.e. in-hospital transition of care, case severity, and mortality due to COVID-19) exist in patients affected by COVID-19.
Inclusion Criteria:
- Patients with laboratory confirmed SARS-Cov-2 infection of any severity.
Exclusion Criteria:
- Pregnancy.
- Younger than 18 years of age.
Sapienza University of Rome - Policlinico Umberto I Roma
Rome, Italy
Investigator: Stefania Basili, MD
Contact: +390649972018
stefania.basili@uniroma1.it
Investigator:
Stefania Basili, MD
0649972018
stefania.basili@uniroma1.it